In addition, ERF and CRM possess in vitro antimicrobial activity against the pathogenic bacterial species Staphylococcus aureus [29], which was shown to accelerate the pathogenesis of CTCL [79,80]. Here, ERF is linked to primary cutaneous T-cell non-Hodgkin lymphoma.